Richardson, P. G. Et Al. 2025. A plain language summary of the ICARIA study, comparing isatuximab–pomalidomide– dexamethasone with pomalidomide– dexamethasone in people with multiple myeloma. Future Oncology .

Richardson, P. G., Perrot, A., San-Miguel, J., BEKSAÇ, M., Spicka, I., Leleu, X., ... Schjesvold, F.(2025). A plain language summary of the ICARIA study, comparing isatuximab–pomalidomide– dexamethasone with pomalidomide– dexamethasone in people with multiple myeloma. Future Oncology .

Richardson, Paul Et Al. "A plain language summary of the ICARIA study, comparing isatuximab–pomalidomide– dexamethasone with pomalidomide– dexamethasone in people with multiple myeloma," Future Oncology , 2025

Richardson, Paul G. Et Al. "A plain language summary of the ICARIA study, comparing isatuximab–pomalidomide– dexamethasone with pomalidomide– dexamethasone in people with multiple myeloma." Future Oncology , 2025

Richardson, P. G. Et Al. (2025) . "A plain language summary of the ICARIA study, comparing isatuximab–pomalidomide– dexamethasone with pomalidomide– dexamethasone in people with multiple myeloma." Future Oncology .

@article{article, author={Paul G. Richardson Et Al. }, title={A plain language summary of the ICARIA study, comparing isatuximab–pomalidomide– dexamethasone with pomalidomide– dexamethasone in people with multiple myeloma}, journal={Future Oncology}, year=2025}